What is ValueAgent?
ValueAgent is an AI investment research tool that generates full-length, institutional-style stock theses for individual investors and analysts. Trained on the frameworks of legendary investors — Warren Buffett, Seth Klarman, and Chris Hohn — the platform's AI agents read public filings and produce a 12,000-word written thesis per ticker in roughly thirty minutes, delivered to your inbox with no login required for the first analysis. Each report includes a multi-scenario DCF valuation (bear, base, and bull intrinsic values), an Earnings Power Value (EPV) calculation, ROIC and revenue CAGR history, a management credibility grade, and a stock-based compensation impact analysis. The output also surfaces four distinct verdict zones — Buy, Watch, Pass, and Avoid — each anchored to a specific margin-of-safety threshold drawn from the named investors' documented criteria. For example, the Klarman zone requires a 30% margin of safety while the Buffett zone targets a wonderful business at fair price. This structured verdict framework lets users immediately see whether a stock meets their own required margin of safety without having to reconstruct the math. The tool is positioned as a best AI for value investing research, specifically for long-term, fundamentals-driven investors who want systematic, Buffett-style analysis at scale. Pricing offers a free first thesis with no credit card, making it accessible for evaluation before committing. Best for: independent value investors, CFA candidates, and small fund analysts who want deep, data-grounded equity write-ups without hiring a research team.
What is ValueAgent used for?
stock investment thesis generation, equity valuation, DCF analysis, value investing research, margin of safety calculation, ROIC analysis, fundamental analysis
How much does ValueAgent cost?
Paid
Paid plans pricing not published — visit value-agents.com for current plans
Pros and cons
Pros
- Generates a full 12,000-word investment thesis per ticker from public filings in ~30 minutes
- Produces multi-scenario DCF valuations (bear/base/bull) plus an Earnings Power Value (EPV) figure
- Verdict zones map each investor style (Buffett, Klarman, Hohn) to explicit price thresholds and margin-of-safety percentages
- Includes ROIC history, revenue CAGR, management credibility grade, and SBC dilution impact analysis
- First thesis is free with no credit card required
Cons
- Full pricing plans beyond the free first thesis are not listed publicly — cost for ongoing use is unknown
- AI-generated theses rely on public filings only; proprietary channel checks or management calls are not included
- Conviction ratings and intrinsic value figures are model outputs, not guaranteed to reflect true business quality
- Coverage scope (which tickers and markets are supported) is not documented on the homepage
Questions about ValueAgent
What is ValueAgent?
ValueAgent is an AI-powered investment research platform that generates 12,000-word stock investment theses by applying the frameworks of Buffett, Klarman, and Hohn to public company filings. Given a ticker symbol, its agents produce a DCF valuation, intrinsic value estimate, margin-of-safety calculation, ROIC history, and a structured Buy/Watch/Pass/Avoid verdict in about 30 minutes.
Is ValueAgent free?
Yes, your first thesis is free with no credit card required. Beyond the free first analysis, paid plan pricing is not publicly listed on the website, so you would need to sign up to see current subscription options.
How does ValueAgent work?
You submit a stock ticker and ValueAgent's AI agents pull data from public filings (10-Ks, etc.) to produce a full investment write-up. The report covers a multi-scenario DCF (bear/base/bull), Earnings Power Value, revenue and ROIC history, management credibility scoring, and stock-based compensation dilution analysis, all framed through the documented investing criteria of Buffett, Klarman, and Hohn.
What does a ValueAgent thesis include?
Each thesis includes an intrinsic value range (DCF bear/base/bull and EPV), a margin-of-safety percentage at the current price, four verdict zones (Buy, Watch, Pass, Avoid) each tied to a specific investor's required margin of safety, a 10-year financial history with CAGR figures, a management credibility grade, and a stock-based compensation impact analysis. The full write-up runs approximately 12,000 words.
ValueAgent vs traditional equity research — what's the difference?
Traditional equity research is produced by human analysts, is expensive to commission, and often takes days or weeks. ValueAgent automates the same structured analysis — DCF, ROIC, management assessment, thesis write-up — in about 30 minutes from publicly available filings, at a fraction of the cost. The trade-off is that it cannot incorporate proprietary data sources, management meetings, or channel checks that human analysts use.
What are the best alternatives to ValueAgent?
Reviews
Sign in to rate and review ValueAgent.
Sign in to reviewNo reviews yet. Be the first to review ValueAgent!